{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T08:07:08Z","timestamp":1778227628812,"version":"3.51.4"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T00:00:00Z","timestamp":1776556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Urol"],"DOI":"10.1007\/s00345-026-06417-x","type":"journal-article","created":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T11:45:40Z","timestamp":1776599140000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["HALP score as a predictor of biochemical recurrence after robot-assisted laparoscopic prostatectomy for localized prostate cancer"],"prefix":"10.1007","volume":"44","author":[{"given":"Adem","family":"Utlu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tugay","family":"Aksakall\u0131","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feyzullah","family":"\u00c7elik","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmet Emre","family":"Cinislio\u011flu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mehmet Sefa","family":"Altay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fevzi","family":"Bedir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"H\u00fcseyin","family":"Kocat\u00fcrk","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u0130brahim","family":"Karabulut","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2026,4,19]]},"reference":[{"key":"6417_CR1","doi-asserted-by":"publisher","DOI":"10.3389\/fpubh.2022.811044","volume":"10","author":"L Wang","year":"2022","unstructured":"Wang L, Lu B, He M, Wang Y, Wang Z, Du L (2022) Prostate cancer incidence and mortality: global status and temporal trends in 89 countries from 2000 to 2019. Front Public Health 10:811044","journal-title":"Front Public Health"},{"issue":"4","key":"6417_CR2","first-page":"271","volume":"66","author":"KD Miller","year":"2016","unstructured":"Miller KD, Siegel RL, Lin CC, Mariotto AB, Kramer JL, Rowland JH, Stein KD, Alteri R, Jemal A (2016) Cancer treatment and survivorship statistics, 2016. CA Cancer J Clin 66(4):271\u2013289","journal-title":"CA Cancer J Clin"},{"issue":"10\u201311","key":"6417_CR3","doi-asserted-by":"publisher","first-page":"889","DOI":"10.1016\/j.clinbiochem.2013.10.023","volume":"47","author":"S Dijkstra","year":"2014","unstructured":"Dijkstra S, Mulders P, Schalken J (2014) Clinical use of novel urine and blood based prostate cancer biomarkers: a review. Clin Biochem 47(10\u201311):889\u2013896","journal-title":"Clin Biochem"},{"issue":"4","key":"6417_CR4","doi-asserted-by":"publisher","first-page":"666","DOI":"10.1016\/j.eururo.2005.11.032","volume":"49","author":"R Svatek","year":"2006","unstructured":"Svatek R, Karakiewicz PI, Shulman M, Karam J, Perrotte P, Benaim E (2006) Pre-treatment nomogram for disease-specific survival of patients with chemotherapy-naive androgen independent prostate cancer. Eur Urol 49(4):666\u2013674","journal-title":"Eur Urol"},{"issue":"38","key":"6417_CR5","doi-asserted-by":"publisher","first-page":"41370","DOI":"10.18632\/oncotarget.5629","volume":"6","author":"X-L Chen","year":"2015","unstructured":"Chen X-L, Xue L, Wang W, Chen H-N, Zhang W-H, Liu K, Chen X-Z, Yang K, Zhang B, Chen Z-X (2015) Prognostic significance of the combination of preoperative hemoglobin, albumin, lymphocyte and platelet in patients with gastric carcinoma: a retrospective cohort study. Oncotarget 6(38):41370","journal-title":"Oncotarget"},{"issue":"44","key":"6417_CR6","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.12271","volume":"7","author":"H Jiang","year":"2016","unstructured":"Jiang H, Li H, Li A, Tang E, Xu D, Chen Y, Zhang Y, Tang M, Zhang Z, Deng X (2016) Preoperative combined hemoglobin, albumin, lymphocyte and platelet levels predict survival in patients with locally advanced colorectal cancer. Oncotarget 7(44):72076","journal-title":"Oncotarget"},{"key":"6417_CR7","doi-asserted-by":"publisher","DOI":"10.12659\/MSM.917968","volume":"25","author":"X-B Shen","year":"2019","unstructured":"Shen X-B, Zhang Y-X, Wang W, Pan Y-Y (2019) The hemoglobin, albumin, lymphocyte, and platelet (HALP) score in patients with small cell lung cancer before first-line treatment with etoposide and progression-free survival. Med Sci Monit 25:5630","journal-title":"Med Sci Monit"},{"issue":"1","key":"6417_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-018-19146-y","volume":"8","author":"D Peng","year":"2018","unstructured":"Peng D, Zhang C-j, Gong Y-q, Hao H, Guan B, Li X-s, Zhou L-q (2018) Prognostic significance of HALP (hemoglobin, albumin, lymphocyte and platelet) in patients with bladder cancer after radical cystectomy. Sci Rep 8(1):794","journal-title":"Sci Rep"},{"issue":"1","key":"6417_CR9","doi-asserted-by":"publisher","first-page":"81","DOI":"10.7150\/jca.27210","volume":"10","author":"Y Guo","year":"2019","unstructured":"Guo Y, Shi D, Zhang J, Mao S, Wang L, Zhang W, Zhang Z, Jin L, Ye L, Yao X (2019) The hemoglobin, albumin, lymphocyte, and platelet (HALP) score is a novel significant prognostic factor for patients with metastatic prostate cancer undergoing cytoreductive radical prostatectomy. J Cancer 10(1):81","journal-title":"J Cancer"},{"issue":"2","key":"6417_CR10","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.juro.2006.10.097","volume":"177","author":"MS Cookson","year":"2007","unstructured":"Cookson MS, Aus G, Burnett AL, Canby-Hagino ED, D\u2019Amico AV, Dmochowski RR, Eton DT, Forman JD, Goldenberg SL, Hernandez J (2007) Variation in the definition of biochemical recurrence in patients treated for localized prostate cancer: the American Urological Association Prostate Guidelines for Localized Prostate Cancer Update Panel report and recommendations for a standard in the reporting of surgical outcomes. J Urol 177(2):540\u2013545","journal-title":"J Urol"},{"issue":"2","key":"6417_CR11","doi-asserted-by":"publisher","first-page":"41","DOI":"10.14712\/fb2001047020041","volume":"47","author":"M Lukes","year":"2001","unstructured":"Lukes M, Urban M, Z\u00e1lesk\u00fd M, Zachoval R, Heracek J, Zd\u00e1rsk\u00fd E (2001) Prostate-specific antigen: current status. Folia Biol 47(2):41\u201349","journal-title":"Folia Biol"},{"issue":"6 Part 1","key":"6417_CR12","doi-asserted-by":"publisher","first-page":"2096","DOI":"10.1016\/S0022-5347(01)62251-1","volume":"160","author":"AV D'amico","year":"1998","unstructured":"D\u2019amico AV, Whittington R, Malkowicz SB, Fondurulia J, Chen M-H, Tomaszewski JE, Wein A (1998) The combination of preoperative prostate specific antigen and postoperative pathological findings to predict prostate specific antigen outcome in clinically localized prostate cancer. J Urol 160(6 Part 1):2096\u20132101","journal-title":"J Urol"},{"issue":"2","key":"6417_CR13","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1016\/j.juro.2008.10.033","volume":"181","author":"J Walz","year":"2009","unstructured":"Walz J, Chun FK-H, Klein EA, Reuther A, Saad F, Graefen M, Huland H, Karakiewicz PI (2009) Nomogram predicting the probability of early recurrence after radical prostatectomy for prostate cancer. J Urol 181(2):601\u2013608","journal-title":"J Urol"},{"issue":"28","key":"6417_CR14","doi-asserted-by":"publisher","first-page":"7005","DOI":"10.1200\/JCO.2005.01.867","volume":"23","author":"AJ Stephenson","year":"2005","unstructured":"Stephenson AJ, Scardino PT, Eastham JA, Bianco FJ Jr, Dotan ZA, DiBlasio CJ, Reuther A, Klein EA, Kattan MW (2005) Postoperative nomogram predicting the 10-year probability of prostate cancer recurrence after radical prostatectomy. J Clin Oncol 23(28):7005\u20137012","journal-title":"J Clin Oncol"},{"key":"6417_CR15","doi-asserted-by":"publisher","DOI":"10.1177\/17588359221100022","volume":"14","author":"A Meisel","year":"2022","unstructured":"Meisel A, de Wit R, Oudard S, Sartor O, Stenner-Liewen F, Shun Z, Foster M, Ozatilgan A, Eisenberger M, de Bono JS (2022) Neutropenia, neutrophilia, and neutrophil\u2013lymphocyte ratio as prognostic markers in patients with metastatic castration-resistant prostate cancer. Ther Adv Med Oncol 14:17588359221100022","journal-title":"Ther Adv Med Oncol"},{"issue":"6","key":"6417_CR16","first-page":"863","volume":"73","author":"A Sciarra","year":"2021","unstructured":"Sciarra A, Gentilucci A, Cattarino S, Salsiccia S, Mariotti G (2021) Prognostic role of platelet-to-lymphocyte ratio and neutrophil-to-lymphocyte ratio in patients with metastatic castration resistant prostate cancer treated with abiraterone or enzalutamide. Minerva Urol Nefrol 73(6):863\u2013865","journal-title":"Minerva Urol Nefrol"},{"issue":"4","key":"6417_CR17","doi-asserted-by":"publisher","first-page":"604","DOI":"10.1038\/s41391-023-00689-9","volume":"27","author":"Y Zheng","year":"2024","unstructured":"Zheng Y, Wang K, Ou Y, Hu X, Wang Z, Wang D, Li X, Ren S (2024) Prognostic value of a baseline prognostic nutritional index for patients with prostate cancer: a systematic review and meta-analysis. Prostate Cancer Prostatic Dis 27(4):604\u2013613","journal-title":"Prostate Cancer Prostatic Dis"},{"key":"6417_CR18","doi-asserted-by":"publisher","DOI":"10.18632\/oncotarget.28367","volume":"14","author":"CM Farag","year":"2023","unstructured":"Farag CM, Antar R, Akosman S, Ng M, Whalen MJ (2023) What is hemoglobin, albumin, lymphocyte, platelet (HALP) score? A comprehensive literature review of HALP\u2019s prognostic ability in different cancer types. Oncotarget 14:153","journal-title":"Oncotarget"},{"issue":"1","key":"6417_CR19","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1016\/j.immuni.2019.06.025","volume":"51","author":"FR Greten","year":"2019","unstructured":"Greten FR, Grivennikov SI (2019) Inflammation and cancer: triggers, mechanisms, and consequences. Immunity 51(1):27\u201341","journal-title":"Immunity"},{"key":"6417_CR20","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1007\/s00508-018-1318-z","volume":"130","author":"M Lucijanic","year":"2018","unstructured":"Lucijanic M, Veletic I, Rahelic D, Pejsa V, Cicic D, Skelin M, Livun A, Tupek KM, Stoos-Veic T, Lucijanic T (2018) Assessing serum albumin concentration, lymphocyte count and prognostic nutritional index might improve prognostication in patients with myelofibrosis. Wien Klin Wochenschr 130:126\u2013133","journal-title":"Wien Klin Wochenschr"},{"key":"6417_CR21","unstructured":"Takenaka A, Masago T, Isoyama T, Yao A, Iwamoto H, Morizane S, Kadowaki H, Sejima T (2012) Low pre-operative levels of serum albumin predict lymph node metastases and ultimately correlate with a biochemical recurrence of prostate cancer in radical prostatectomy patients. Central Eur J Urol 66(2)"},{"issue":"2","key":"6417_CR22","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1093\/carcin\/bgu247","volume":"36","author":"X Liu","year":"2015","unstructured":"Liu X, Meng QH, Ye Y, Hildebrandt MA, Gu J, Wu X (2015) Prognostic significance of pretreatment serum levels of albumin, LDH and total bilirubin in patients with non-metastatic breast cancer. Carcinogenesis 36(2):243\u2013248","journal-title":"Carcinogenesis"},{"key":"6417_CR23","doi-asserted-by":"publisher","first-page":"989","DOI":"10.1007\/s00404-017-4511-9","volume":"296","author":"A Ayhan","year":"2017","unstructured":"Ayhan A, G\u00fcnakan E, Alyaz\u0131c\u0131 \u0130, Haberal N, Altunda\u011f \u00d6, Dursun P (2017) The preoperative albumin level is an independent prognostic factor for optimally debulked epithelial ovarian cancer. Arch Gynecol Obstet 296:989\u2013995","journal-title":"Arch Gynecol Obstet"},{"issue":"12","key":"6417_CR24","doi-asserted-by":"publisher","first-page":"2214","DOI":"10.1002\/1097-0142(20010615)91:12<2214::AID-CNCR1251>3.0.CO;2-P","volume":"91","author":"JJ Caro","year":"2001","unstructured":"Caro JJ, Salas M, Ward A, Goss G (2001) Anemia as an independent prognostic factor for survival in patients with cancer: a systemic, quantitative review. Cancer 91(12):2214\u20132221","journal-title":"Cancer"},{"key":"6417_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12885-018-4064-8","volume":"18","author":"J-A Lim","year":"2018","unstructured":"Lim J-A, Oh C-S, Yoon T-G, Lee JY, Lee S-H, Yoo Y-B, Yang J-H, Kim S-H (2018) The effect of propofol and sevoflurane on cancer cell, natural killer cell, and cytotoxic T lymphocyte function in patients undergoing breast cancer surgery: an in vitro analysis. BMC Cancer 18:1\u20138","journal-title":"BMC Cancer"},{"issue":"7","key":"6417_CR26","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1038\/sj.bjp.0706013","volume":"143","author":"P Jurasz","year":"2004","unstructured":"Jurasz P, Alonso-Escolano D, Radomski MW (2004) Platelet\u2013cancer interactions: mechanisms and pharmacology of tumour cell-induced platelet aggregation. Br J Pharmacol 143(7):819","journal-title":"Br J Pharmacol"},{"issue":"3","key":"6417_CR27","doi-asserted-by":"publisher","first-page":"313","DOI":"10.29271\/jcpsp.2022.03.313","volume":"32","author":"F Ekinci","year":"2022","unstructured":"Ekinci F, Balcik OY, Oktay E, Erdogan AP (2022) HALP score as a new prognostic index in metastatic renal cell cancer. J Coll Physicians Surg Pak 32(3):313\u2013318","journal-title":"J Coll Physicians Surg Pak"},{"issue":"3","key":"6417_CR28","doi-asserted-by":"publisher","DOI":"10.1111\/ijcp.13766","volume":"75","author":"C Kaya","year":"2021","unstructured":"Kaya C, Caliskan S, Sungur M, Ayd\u0131n C (2021) HALP score and albumin levels in men with prostate cancer and benign prostate hyperplasia. Int J Clin Pract 75(3):e13766","journal-title":"Int J Clin Pract"},{"issue":"2","key":"6417_CR29","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1177\/03915603241292199","volume":"92","author":"O Ekici","year":"2025","unstructured":"Ekici O, Akgun U, Buyukdemirci E, Avci S, Caglayan V, Erdogan A, Onen E, Ozcan R, Oner S (2025) Association of hemoglobin, albumin, lymphocyte and platelet (HALP) score with testicular tumor aggressiveness and prognosis. Urologia 92(2):317\u2013323","journal-title":"Urologia"},{"key":"6417_CR30","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2022.109496","volume":"114","author":"H Xu","year":"2023","unstructured":"Xu H, Zheng X, Ai J, Yang L (2023) Hemoglobin, albumin, lymphocyte, and platelet (HALP) score and cancer prognosis: a systematic review and meta-analysis of 13,110 patients. Int Immunopharmacol 114:109496","journal-title":"Int Immunopharmacol"}],"container-title":["World Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00345-026-06417-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00345-026-06417-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T11:45:41Z","timestamp":1776599141000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00345-026-06417-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,19]]},"references-count":30,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6417"],"URL":"https:\/\/doi.org\/10.1007\/s00345-026-06417-x","relation":{},"ISSN":["1433-8726"],"issn-type":[{"value":"1433-8726","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,19]]},"assertion":[{"value":"2 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This study was approved by the Erzurum Medicine Faculty University Local Ethics Committee (approval number: BAEK 2024\/12-231).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Trial registration"}}],"article-number":"312"}}